- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02121769
Omegaven Expanded Access Protocol
April 8, 2019 updated by: Tyler Burpee, MD, St. Luke's Health System, Boise, Idaho
Protocol for Patients With Parenteral Nutrition Associated Liver Disease (PNALD) to Access Parenteral Fish Oil (Omegaven®) - Omegaven IND 122375
Omegaven is an intravenous fat emulsion (IFE) comprised of omega-3 fatty acids derived from fish oil.
It will be used in an open label compassionate use treatment protocol, as an alternative to soybean oil (omega-6), as the sole IFE source of parenteral nutrition in an effort to reduce and/or reverse parenteral nutrition associated liver disease.
The study will evaluate the safety and efficacy of Omegaven use in pediatric patients with PN dependence and PNALD.
Study Overview
Status
No longer available
Intervention / Treatment
Study Type
Expanded Access
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Idaho
-
Boise, Idaho, United States, 83712
- St. Luke's Pediatric Gastroenterology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 17 years (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients will be PN dependent (unable to meet nutritional needs solely by enteral nutrition) and are expected to require PN for at least another 30 days
- Parenteral nutrition associated liver disease (PNALD) as defined as a direct bilirubin of ≥ 2 mg/dL on the last two consecutive bilirubins while on PN. Other causes of liver disease should be excluded. A liver biopsy is not necessary for treatment.
- Failed standard/conventional therapies to prevent progression of PNALD.
- Age newborn to 17 years of age
- Signed informed consent.
Exclusion Criteria:
- Allergy to eggs and/or shellfish
- Female who is pregnant or lactating
- Severe hemorrhagic disorder
- Other causes of chronic liver disease (Hepatitis C, Cystic fibrosis, biliary atresia, and alpha 1 anti-trypsin deficiency,)
- 18 years of age or older
- Parent/legally authorized representative is unwilling to consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tyler Burpee, MD, Pediatric Gastroenterology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
April 21, 2014
First Submitted That Met QC Criteria
April 23, 2014
First Posted (Estimate)
April 24, 2014
Study Record Updates
Last Update Posted (Actual)
April 10, 2019
Last Update Submitted That Met QC Criteria
April 8, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Omegaven Expanded Access
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parenteral Nutrition Associated Liver Disease
-
Vanderbilt University Medical CenterCompletedUse of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver DiseaseParenteral Nutrition Associated Liver DiseaseUnited States
-
Cook Children's Health Care SystemNo longer availableParenteral Nutrition-Associated Liver DiseaseUnited States
-
University of TennesseeUnknownParenteral Nutrition Associated Liver DiseaseUnited States
-
University of CalgaryCompletedOlive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical OutcomesParenteral Nutrition Associated Liver Disease
-
DHR Health Institute for Research and DevelopmentApproved for marketingParenteral Nutrition Associated Liver Disease
-
Children's Medical Center DallasCompletedLiver Disease | Parenteral Nutrition Associated Liver Disease | Impaired Liver FunctionUnited States
-
University of NebraskaCompletedCholestasis | Parenteral Nutrition Associated Liver Disease PNALDUnited States
-
Children's & Women's Health Centre of British ColumbiaChild and Family Research InstituteUnknownCholestasis | Parenteral Nutrition Associated Liver Disease (PNALD)Canada
-
Fresenius KabiNot yet recruitingMalnutrition | Pediatric ALL | Essential Fatty Acid Deficiency | Parenteral Nutrition Associated Liver Disease (PNALD)
-
Yale UniversityUniversity of California, Los Angeles; Northwestern University Feinberg School...CompletedParenteral Nutrition-Associated Liver DiseaseUnited States
Clinical Trials on Omegaven
-
Children's & Women's Health Centre of British ColumbiaChild and Family Research InstituteUnknownCholestasis | Parenteral Nutrition Associated Liver Disease (PNALD)Canada
-
National Taiwan University HospitalUnknownCritical Ill Patients in SICUTaiwan
-
Midwestern Regional Medical CenterTerminatedCancer | Hepatic InjuryUnited States
-
Jagiellonian UniversityCompletedGastrointestinal SurgeryPoland
-
Li Shin HospitalCompleted
-
Mark PuderCompletedGastrointestinal Disease | Short Bowel Syndrome | Parenteral Nutrition Associated Liver DiseaseUnited States
-
Rush University Medical CenterApproved for marketingCholestasis | Total Parenteral Nutrition-induced CholestasisUnited States
-
DHR Health Institute for Research and DevelopmentApproved for marketingParenteral Nutrition Associated Liver Disease
-
General University Hospital, PragueCharles University, Czech Republic; Ministry of Health, Czech RepublicCompletedParenteral NutritionCzechia